Congress

← vista completa

Published on June 1, 2003 | http://doi.org/10.5867/medwave.2003.05.787

Effect of NSAIDs on the gastrointestinal tract: prevention of lesions

Efecto de los antiinflamatorios no esteroidales sobre el tubo digestivo: prevención de lesiones

Charles M. Wilcox

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Charles M. Wilcox

University of Alabama, Tuscaloosa, Alabama, Estados Unidos

Figures

Article has no figures.

Forum

No messages

History

Citation Wilcox CM. Effect of NSAIDs on the gastrointestinal tract: prevention of lesions. Medwave 2003;3(05):e787 doi: 10.5867/medwave.2003.05.787

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/06/2003

Index

Metrics

Not available at the moment.

Notes

References

  1. Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1995 Aug 15;123(4):241-9. | PubMed
  2. Labenz J, Blum AL, Bolten WW, Dragosics B, Rösch W, Stolte M, et al. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in H pylori positive patients: a randomized, double blind, placebo controlled, clinical trial. Gut. 2002 Sep;51(3):329-35. | CrossRef | PubMed
  3. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al. Gastrointestinal Toxicity with celecoxib vs nonseteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. JAMA. 2000 Sep 13;284(10):1247-55. | CrossRef | PubMed
  4. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of robecoxib and naproxen in patients with rheumatoid arthritis. For the VIGOR study group. N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. | PubMed